Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2003
10/01/2003EP1051393B1 New derivatives of sulfonic, phosphonic and phosphinic aminoalkane acids, their production and their use as medicaments
10/01/2003EP1037666B1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides
10/01/2003EP1019434B1 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis
10/01/2003EP1014998B1 Polymeric compositions
10/01/2003EP1001944B1 Pyrazine derivatives, preparation and medicines containing them
10/01/2003EP1000029B1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
10/01/2003EP0999825B1 Ophthalmic compositions containing galactomannan polymers and borate
10/01/2003EP0998473B1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
10/01/2003EP0998455B1 Dihomo-seco-cholestanes with two unsaturated bonds in the side chain
10/01/2003EP0998266B1 Microcrystalline cellulose: alginate pharmaceutical suspensions
10/01/2003EP0996621B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS
10/01/2003EP0988310B1 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
10/01/2003EP0977558B1 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
10/01/2003EP0970079B1 Farnesyl transferase inhibiting 1,8-annelated quinolinone derivatives substituted with n- or c-linked imidazoles
10/01/2003EP0966448B1 Pyrazine compounds
10/01/2003EP0944595B1 5-cyclo indole compounds as 5-ht1d receptor ligands
10/01/2003EP0920426B1 New thiazole derivatives with phosphodiesterase-inhibiting effect
10/01/2003EP0914098B1 Multi-layered osmotic device
10/01/2003EP0891331B1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity
10/01/2003EP0871361B1 Agent for combating parasites in farmed fish
10/01/2003EP0863917B1 Targeted cytotoxic anthracycline analogs
10/01/2003EP0833606B1 Stable hydroalcoholic compositions
10/01/2003EP0820273B1 Use of sophorolipids in cosmetic and dermatological compositions
10/01/2003EP0814780B1 Diltiazem controlled release formulation
10/01/2003EP0811008B1 Bicyclic benzazepine derivatives as vasopressin antagonists
10/01/2003EP0810854B1 Aerosols containing beclomethazone nanoparticle dispersions
10/01/2003EP0772596B1 INDOLIZINE sPLA2 INHIBITORS
10/01/2003EP0758882B1 Use of n-acetyl-l-cysteine for lightening hyperpigmented skin
10/01/2003CN1446261A Modified cytokines for use in cancer therapy
10/01/2003CN1446228A 校正基因 Correction gene
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1446225A 5'-deoxy-N-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
10/01/2003CN1446220A Method for the production of imidazo-[1,2-c] [2,3]-benzodiazepines and intermediates in production thereof
10/01/2003CN1446218A Benzimidazole derivatives, preparation method and therapeutic use thereof
10/01/2003CN1446217A Beta-carboline derivatives useful as inhibitors of phosphodiesterase
10/01/2003CN1446216A Indole derivatives useful for treatment of CNS disorders
10/01/2003CN1446214A Cinnoline compounds
10/01/2003CN1446213A Medicinal compositions containing propenone derivatives
10/01/2003CN1446212A Quinoline derivatives having VEGF inhibiting activity
10/01/2003CN1446211A Indole derivatives useful for treatment of CNS disorders
10/01/2003CN1446207A Process for preparation of baccatin Ôàó derivatives
10/01/2003CN1446202A 2-aminopyridine compounds and use thereof as drugs
10/01/2003CN1446201A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/01/2003CN1446200A Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-ichibiting anti-inflammatory and immune-suppressive agents
10/01/2003CN1446199A New amidino derivatives and their use as thrombin inhibitors
10/01/2003CN1446197A Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
10/01/2003CN1446193A Aminoadamantane derivatives as therapeutic agents
10/01/2003CN1446111A Microencapsulated fragrances and methods of coating microcapsules
10/01/2003CN1446108A Pharmaceutical form comprising a support material and at least a cell regulating factor and/or cell proliferation promoter
10/01/2003CN1446106A Method of treating estrogen receptor positive carcinoma
10/01/2003CN1446105A Medicinal compositions for angiogenic therapy
10/01/2003CN1446104A Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
10/01/2003CN1446097A Use of derivatives of valproic acid and 2-valproenic acid amides for treatment of mania in bipolar disorder
10/01/2003CN1446093A Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity
10/01/2003CN1446092A Aqueous pharmaceutical compositions
10/01/2003CN1446091A Daily treatment for erectile dysfunction using PDES inhibitor
10/01/2003CN1446090A Pharmaceutical composition comprising metformin and 5-phenoxyalkyl-2, 4-thiazolidinedione-type derivative
10/01/2003CN1446089A Pharmaceutical composition containing citalopram
10/01/2003CN1446088A Highly purified simvastatin compositions
10/01/2003CN1446087A Use of lipase inhibitors
10/01/2003CN1446086A Use of estramustine phosphate in treatment of bone metastasis
10/01/2003CN1446085A Method for treatment of climacteric disorders in woman during or after the menopause
10/01/2003CN1446084A Treatment of insulin resistance syndrome
10/01/2003CN1446083A Coated medicament forms with controlled active substance rdease
10/01/2003CN1446081A 神经毒素植入物 Neurotoxin implants
10/01/2003CN1446080A Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
10/01/2003CN1446079A Liposomal antineoplastic drugs and uses thereof
10/01/2003CN1446078A Concentrated solution of non-foaming ammonium compounds and method of use
10/01/2003CN1446054A Composition and use
10/01/2003CN1446053A Food supplement
10/01/2003CN1445244A Lilyturf root polysaccharide MDG-1 and its separation method and application
10/01/2003CN1445228A Application of active ingredient of coumarin category distilled from dahurian angelica in preparing medicine for curing high blood pressure and its extracting method
10/01/2003CN1445226A New cornpound derivated from quinazoline, itd preparation method and medicinal composite containig them
10/01/2003CN1445225A Intermediate for preparing benzothiophene amide derivate
10/01/2003CN1445222A Benzofuran category compound, its preparing method and usage
10/01/2003CN1445221A Pharmaceutical application of derivant of benzofuran-ketone
10/01/2003CN1445220A Lactone category compound of sweetsop as well as new usage in medicines and its preparing method
10/01/2003CN1445218A 3-phenyl pyrazole-5-ramification of carboxylic acid derivative as well as its preparing method and medicine appliction
10/01/2003CN1445217A Substitutional ramification of tetrahydro-isoquinoline, as well as its preparing method and its medication compound containing them
10/01/2003CN1445211A New amide ramification of sweetsop as well as its preparing method, its medication composition and usage
10/01/2003CN1445195A Complex super fine powder of copper-zinc compound as well as its preparing technique and usage
10/01/2003CN1444990A Strengthened ganoderma lucidum for possible immunoprophylaxis and immunotherapy of cancers and related diseases as well as its preparing method
10/01/2003CN1444981A Medicine for treating cardiovascular diseases and its preparing method
10/01/2003CN1444976A Preparation of Chinese herbal medicine for treating cold injury, various indurations and swelling, pain as well as its preparing method
10/01/2003CN1444964A Application of ÔÇÿWurenchunÔÇÖ capsule for preparing medicine of treating sleep disorder
10/01/2003CN1444949A Astragalus root valid part of Chinese herbal medicine for treating cardiovascular disease
10/01/2003CN1444948A Liposome of Breviscapine and its preparing method
10/01/2003CN1444947A Breviscapine drop pills and its preparing method
10/01/2003CN1444946A Method for preparing nano-microballons of Avermectins medicine and usage
10/01/2003CN1444945A Medicine containing fritillary total alkali for treating disease of respiratory system and its preparing method
10/01/2003CN1444944A Cyclovirobuxinum D. drop pills and its preparing method
10/01/2003CN1444943A Pentoxifylline tablet controlled relasease tablet
10/01/2003CN1444942A 偏头痛治疗药 Migraine therapeutic agent
10/01/2003CN1444941A Usage of substituted tetrahydroisoquinoline derviation
10/01/2003CN1444940A Cresol powder with dissolution increased and its preparing method-analgesic, antipyretic and anti-inflammatory agent
10/01/2003CN1444939A Usage of total alkaloid of coftis root, phellodendron bark and ÔÇÿSankezhenÔÇÖ as their preparing method
10/01/2003CN1444938A Metronidazole, Clotrimazole and Chlorhexidime Acetate preparation and its preparing method
10/01/2003CN1444937A Drop pills of andrographolide and its preparing method
10/01/2003CN1444936A Drop pills of ÔÇÿWurenchunÔÇÖ and its preparing method
10/01/2003CN1444935A Application of Epigallocatechin gallate (EGCG) in anti-tumor medicine